» Articles » PMID: 21569457

CD4+ T Cells Spontaneously Producing Human Immunodeficiency Virus Type I in Breast Milk from Women with or Without Antiretroviral Drugs

Overview
Journal Retrovirology
Publisher Biomed Central
Specialty Microbiology
Date 2011 May 17
PMID 21569457
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Transmission of human immunodeficiency virus type 1 (HIV-1) through breast-feeding may involve both cell-free and cell-associated virus. This latter viral reservoir remains, however, to be fully explored. CD4+ T cell-associated virus production in breast milk was therefore investigated.

Methods: The ex vivo spontaneous production of HIV-1 antigen and HIV-1 RNA by CD4+ T cells was measured in paired blood and breast milk samples from 15 HIV-1 infected women treated or not with antiretroviral drugs. Spontaneous antigen secreting cells (HIV-1-AgSCs) from breast milk and blood were enumerated by an ELISpot assay, and cell-associated HIV-1 RNA was quantified by real-time PCR in supernatants of CD4+ T cells cultured for 18 hours without addition of polyclonal activators.

Results: Among the CD4+ T cells present in breast milk, memory cells expressing high levels of cell-surface activation markers were predominant. Spontaneous HIV-1-AgSCs were detected and enumerated in the breast milk of all 15 women, with a median number of 13.0 and 9.5 HIV-1- AgSCs/106 CD4+ T cells in aviremic (n = 7) and viremic (n = 8) women, respectively. Cell- associated HIV-1 RNA was detected in cell-free supernatants from 4/7 aviremic and 5/8 viremic individuals at median levels of 190 and 245 copies/ml, respectively.

Conclusions: Activated CD4+ T cells producing HIV-1 are detected in the breast milk of untreated individuals as well as those receiving highly active antiretroviral therapy. This finding strongly suggests that HIV-1 replication occurs in latently infected CD4+ T cells that, upon spontaneous activation, revert to productively infected cells. These cells might be responsible for a residual breast milk transmission despite maternal highly active antiretroviral therapy.

Citing Articles

Secretory IgA and T cells targeting SARS-CoV-2 spike protein are transferred to the breastmilk upon mRNA vaccination.

Goncalves J, Juliano A, Charepe N, Alenquer M, Athayde D, Ferreira F Cell Rep Med. 2021; 2(12):100468.

PMID: 34873588 PMC: 8636305. DOI: 10.1016/j.xcrm.2021.100468.


The immune response to sub-clinical mastitis is impaired in HIV-infected women.

Schaub R, Badiou S, Viljoen J, Dujols P, Bollore K, Van de Perre P J Transl Med. 2018; 16(1):296.

PMID: 30359283 PMC: 6202806. DOI: 10.1186/s12967-018-1667-4.


Breastfeeding-related maternal microchimerism.

Moles J, Tuaillon E, Kankasa C, Bedin A, Nagot N, Marchant A Nat Rev Immunol. 2017; 17(11):729-1.

PMID: 28972205 DOI: 10.1038/nri.2017.115.


Maternal and Breastmilk Viral Load: Impacts of Adherence on Peripartum HIV Infections Averted-The Breastfeeding, Antiretrovirals, and Nutrition Study.

Davis N, Miller W, Hudgens M, Chasela C, Sichali D, Kayira D J Acquir Immune Defic Syndr. 2016; 73(5):572-580.

PMID: 27846071 PMC: 5141681. DOI: 10.1097/QAI.0000000000001145.


Second European Round Table on the Future Management of HIV: 10-11 October 2014, Barcelona, Spain.

Rokx C, Richman D, Muller-Trutwin M, Silvestri G, Lunzen J, Khoo S J Virus Erad. 2016; 1(3):211-20.

PMID: 27482415 PMC: 4946744.


References
1.
Richardson B, John-Stewart G, Hughes J, Nduati R, Mbori-Ngacha D, Overbaugh J . Breast-milk infectivity in human immunodeficiency virus type 1-infected mothers. J Infect Dis. 2003; 187(5):736-40. PMC: 3382109. DOI: 10.1086/374272. View

2.
Fawzi W, Msamanga G, Spiegelman D, Renjifo B, Bang H, Kapiga S . Transmission of HIV-1 through breastfeeding among women in Dar es Salaam, Tanzania. J Acquir Immune Defic Syndr. 2002; 31(3):331-8. DOI: 10.1097/00126334-200211010-00010. View

3.
Furtado M, Callaway D, Phair J, Kunstman K, Stanton J, Macken C . Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapy. N Engl J Med. 1999; 340(21):1614-22. DOI: 10.1056/NEJM199905273402102. View

4.
HEAD J, Beer A, Billingham R . Significance of the cellular component of the maternal immunologic endowment in milk. Transplant Proc. 1977; 9(2):1465-71. View

5.
van de Perre P, Simonon A, Hitimana D, Dabis F, Msellati P, Mukamabano B . Infective and anti-infective properties of breastmilk from HIV-1-infected women. Lancet. 1993; 341(8850):914-8. DOI: 10.1016/0140-6736(93)91210-d. View